Ambrx Biopharma (AMAM) Stock Tumbles by 18.65% on October 16
Ambrx Biopharma (AMAM) witnessed a sharp decline on October 16, 2023, with its stock plunging 18.65%, resulting in a substantial loss of $2.62 per share.
by Surya
Published Oct 17, 2023 | Updated Oct 17, 2023 | 📖 1 min read
Article continues below advertisement
Ambrx Biopharma (AMAM) Stock Tumbles by 18.65%
Ambrx Biopharma
NASDAQ: AMAM
October 16th, 2023: $11.43
−2.62 (18.65%)
|
Opening Price |
$16.21 |
After-Hours |
$10.70 |
|
Daily High |
$16.28 |
After-Hours Increase |
6.39% |
|
Daily Low |
$8.20 |
52-Week High |
$16.86 |
|
Closing Price |
$11.43 |
52-Week Low |
$0.38 |
|
Decrease |
18.65% or -$2.62 |
Market Cap |
$4.94B USD |
On October 16th, 2023, Ambrx Biopharma (NASDAQ: AMAM) exhibited a significant drop in value compared to the previous day's closing price of $14.05. The stock opened at $16.21, which was notably lower than the prior day's closing price of $14.05. Throughout the trading day, AMAM experienced a price range between the daily high of $16.28 and the low of $8.20, reflecting a considerable intraday fluctuation. It eventually closed at $11.43, signifying a 18.65% or − $2.62 decrease from the previous day's value. After hours, AMAM saw a slight decrease, with the price at $10.70, indicating a 6.39% increase.
Ambrx Biopharma's 52-week performance demonstrated a substantial variance, with the stock's highest point in the past year reaching $16.86 and the lowest at $0.38. The market capitalization stood at an impressive $4.94B USD.
Related Articles
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.